Radiopharm Theranostics says Phase 3 imaging trial of RAD101 in recurrent brain metastases expected to start in Q1 2027

Radiopharm Theranostics says its Phase 3 imaging trial of RAD101 in recurrent brain metastases is expected to start in Q1 2027.

Detected & updated continuously · Source: Nebula